Project Details
Abstract
Interferons have long been used for the treatment of a variety of cancers and viral
infection diseases. However, we found in our previous study that a number of
downsteam proteins of IFN were highly expressed in OSCC patients' tissue. Treating
the cultured OSCC cell lines with IFN-β resulted in the enhanced cell mobility.
Further quantitative proteomics and phosphoproteomics analyses revealed that in
addition to the classical IFN-inducible proteins, a great number of proteins were also
regulated by unknown mechanisms. Among those targets, several E3 ligases showed
significant changes in either protein expression or phosphorylation levels. Such
regulation mechanisms at degradation level have rare been discussed for IFN
signaling pathways. Therefore, it is interesting to perform an in-depth analysis on this
system. Since current proteomics approaches used in discovery phase possess low
reproducibility, repeated experiments is suggested for getting reliable results. The
common outcome is the reduction of the size of datasets. In this proposed project, we
will establish a quantitative workflow which combines the shotgun approach with a
directed strategy in the discovery phase. We expect that this strategy will increase the
coverage of proteomes and reliability of quantification results when it is applied to the
study of interferon triggered signaling events. Finally, the identified regulation
mechanisms will be evaluated by using suitable inhibitors and antibody-based assays.
Project IDs
Project ID:PC10108-0289
External Project ID:NSC101-2320-B182-012
External Project ID:NSC101-2320-B182-012
Status | Finished |
---|---|
Effective start/end date | 01/08/12 → 31/07/13 |
Keywords
- Interferon
- phosphoproteomics
- mass spectrometry
- quantitative proteomics
- stable isotope labeling
- protein turnover
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.